Clarice Motter
Directeur Financier/CFO chez Vapogenix, Inc.
Profil
Clarice Motter is currently the Chief Financial Officer at Vapogenix, Inc. She has previously worked as a Consultant at LifeCell Corp.
and Repros Therapeutics, Inc., as well as a Senior Accountant at KPMG Peat Marwick LLP.
She has also held the position of Chief Financial Officer at Endovasc, Inc., ThromboVision, Inc., ChaseCom LP, MicroMed Cardiovascular, Inc., and Ensysce Biosciences, Inc. Additionally, she has worked as a Consultant at MicroMed Technology, Inc. and Chrysalis BioTherapeutics, Inc. Ms. Motter has an undergraduate degree and an MBA from the University of California, Berkeley, and an MBA from the UCLA Anderson School of Management.
Postes actifs de Clarice Motter
| Sociétés | Poste | Début |
|---|---|---|
Vapogenix, Inc.
 Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Directeur Financier/CFO | - |
Anciens postes connus de Clarice Motter
| Sociétés | Poste | Fin |
|---|---|---|
MicroMed Cardiovascular, Inc.
 MicroMed Cardiovascular, Inc. Medical SpecialtiesHealth Technology MicroMed Cardiovascular, Inc. is a medical company engaged in the manufacture and distribution of miniaturized heart pump known as the DeBakey VAD to address congestive heart failure. The company was founded on October 6, 1995 is headquartered in Houston, TX. | Directeur Financier/CFO | 27/11/2006 |
Endovasc, Inc.
 Endovasc, Inc. Financial ConglomeratesFinance Endovasc, Inc. provides long-term debt and equity investment capital to its portfolio companies. The company's investment portfolio consists primarily of loans with equity features and equity investments in companies which constitutes a controlling equity interest, and debt obligations. Its investment objective is to achieve current income and capital gains. It was founded on June 6, 1996. | Directeur Financier/CFO | 09/10/2006 |
Ensysce Biosciences, Inc. /Old/
 Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Ensysce Biosciences, Inc. supplies drugs for pain and cancer markets. Its technologies include opioid drug abuse-resistant, single-walled carbon nanotubes, SWCNT-immuno and gene therapy and BIO-MD prodrug technology. The company was founded by Bob G. Gower and William H.C. Chang in 2008 and is headquartered in San Diego, CA. | Directeur Financier/CFO | - |
| KPMG Peat Marwick LLP | Comptroller/Controller/Auditor | - |
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Corporate Officer/Principal | - |
Formation de Clarice Motter
| University of California, Berkeley | Masters Business Admin |
| UCLA Anderson School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Endovasc, Inc.
Endovasc, Inc. Financial ConglomeratesFinance Endovasc, Inc. provides long-term debt and equity investment capital to its portfolio companies. The company's investment portfolio consists primarily of loans with equity features and equity investments in companies which constitutes a controlling equity interest, and debt obligations. Its investment objective is to achieve current income and capital gains. It was founded on June 6, 1996. | Finance |
MicroMed Technology, Inc.
 MicroMed Technology, Inc. Electronic Equipment/InstrumentsElectronic Technology MicroMed Technology, Inc. used to develop medical products for patients with end-stage and congestive heart failure (CHF). The company was located in Houston, TX. | Electronic Technology |
ThromboVision, Inc.
 ThromboVision, Inc. Medical SpecialtiesHealth Technology ThromboVision, Inc. develops diagnostics products. It is a biomedical company which enables people to lead longer and healthier lives. The firm provides easy-to-use, rapid-response and versatile clinical diagnostic discoveries that advance medical diagnosis. The company was founded by Kenneth A. Solen, Edward R. Teitel and Sivaprasad Sukavaneshvar in 2005 and is headquartered in Houston, TX. | Health Technology |
Vapogenix, Inc.
Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Health Services |
| KPMG Peat Marwick LLP | Commercial Services |
Chrysalis BioTherapeutics, Inc.
 Chrysalis BioTherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Capstone Therapeutics Corp., Chrysalis BioTherapeutics, Inc. develops therapeutics to accelerate the healing of hard and soft tissue. The company is based in Galveston, TX. The company was founded by Dennis L. McWilliams. Chrysalis BioTherapeutics was acquired by Capstone Therapeutics Corp. on August 06, 2004 for $34.50 million. | Health Technology |
ChaseCom LP
 ChaseCom LP Miscellaneous Commercial ServicesCommercial Services ChaseCom LP provides customer contact center services. The company provides clients with cost effective solutions for ever-changing customer demands, including innovative and strategic customer relationship management, 24/7 back-office technology, order input/provisioning, and post sale support. It also offers inbound and outbound telecommunications operations outsourcing, telemarketing, and staffing solutions. The company was founded in 1998 and is headquartered in Houston, TX. | Commercial Services |
MicroMed Cardiovascular, Inc.
MicroMed Cardiovascular, Inc. Medical SpecialtiesHealth Technology MicroMed Cardiovascular, Inc. is a medical company engaged in the manufacture and distribution of miniaturized heart pump known as the DeBakey VAD to address congestive heart failure. The company was founded on October 6, 1995 is headquartered in Houston, TX. | Health Technology |
Ensysce Biosciences, Inc. /Old/
Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Ensysce Biosciences, Inc. supplies drugs for pain and cancer markets. Its technologies include opioid drug abuse-resistant, single-walled carbon nanotubes, SWCNT-immuno and gene therapy and BIO-MD prodrug technology. The company was founded by Bob G. Gower and William H.C. Chang in 2008 and is headquartered in San Diego, CA. | Distribution Services |
